Adiponectin: An enlarging role in acute kidney injury

Kidney International

Volumn 83, Issue 4, 2013, Pages 546-548

  Oh, Jieun ^a   Rabb, Hamid ^b  

^a Hallym University College of Medicine   (South Korea)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RECOMBINANT PROTEIN;

ACUTE KIDNEY FAILURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; INSULIN RESISTANCE; MACROPHAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; REPERFUSION INJURY; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TREATMENT RESPONSE;

EID: 84875734404     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.479     Document Type: Note

References (13)

1. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783.
2. Scherer PE, Williams S, Fogliano M et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
3. Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769.
4. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 2008; 121: 326-330.
5. Tao L, Gao E, Jiao X et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 2007; 115: 1408-1416.
6. Nishimura M, Izumiya Y, Higuchi A et al. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008; 117: 216-223.
7. Takemura Y, Ouchi N, Shibata R et al. Adiponectin modulates inflammatory reaction via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest 2007; 117: 375-386.
8. Jin X, Chen J, Hu Z et al. Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int 2013; 83: 604-614.
9. Jang HR, Ko GJ, Wasowska BA et al. The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med 2009; 87: 859-864.
10. Rabb H. The promise of immune cell therapy for acute kidney injury. J Clin Invest 2012; 122: 3852-3854.
11. Jung MY, Kim HS, Hong JH et al. Adiponectin induces DC activation via PLCg/JNK/NF-kB pathways, leading to Th1 and Th17 polarization. J Immunol 2012; 188: 2592-2601.
12. Cheng X, Folco EJ, Shimizu K et al. Adiponectin induces pro-inflammatory programs in human macrophages and CD4\+ T cells. J Biol Chem 2012; 287: 36896-36904.
13. Cheng CF, Lian WS, Chen SH et al. Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARalpha-heme oxygenase-1 signaling pathway. J Cell Physiol 2012; 227: 239-249.